Arena Pharmaceuticals, Inc. (NASDAQ:ARNA)

Headlines for Arena Pharmaceuticals, Inc.

Arena Loss Wider Than Expected
Zacks.com - 8 hours ago
Arena Pharmaceuticals, Inc.'s (ARNA - Analyst Report) fourth quarter fiscal 2009 net loss per share came in at 38 cents (excluding special items), wider than the Zacks Consensus Estimate of a loss ...
Looking at Medicines Co. performance since earnings; MDCO, ARNA, ISPH
Learning Markets - 12 hours ago
Earnings releases can make investing tricky. Many traders try to time trades based on earnings filings, but usually find such trading is difficult and dangerous. It is often better to take a look ...
Trading Update for Arena Pharmaceuticals (ARNA)
Market Intellisearch - Mar 16, 2010
ARNA options saw interesting call activity today. A total of 113 put and 1,467 call contracts were traded raising a low Put/Call volume alert. Today's traded Put/Call ratio is 0.08. There were 12 ...
Arena Pharmaceuticals Announces Fourth Quarter and Full Year 2009 Financial Results
PR-CANADA.net - Mar 15, 2010
Arena Pharmaceuticals, Inc. today reported financial results for the fourth quarter and full year ended December 31, 2009. Arena reported a lower net loss allocable to common stockholders in the ...
Arena Pharmaceuticals Q4 net loss narrows
Trading Markets - Mar 15, 2010
Arena Pharmaceuticals, a biopharmaceutical company, has reported that net loss allocable to common stockholders was $29.77 million, or $0.32 per share, for the fourth quarter ended December 31 ...